Your Health Plan:
Your Health Plan:
Not SelectedIMATINIB (imatinib mesylate) is a generic prescription drug for treatment of Hypereosinophilic syndrome. IMATINIB is a kinase inhibitor. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $14-35.
No saving program is found for IMATINIB.
Other alternatives to IMATINIB may include:
